Martingale Asset Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-44,400
| Closed | -$17.3M | – | 779 |
|
|
2025
Q2 | $17.3M | Buy |
44,400
+24,990
| +129% | +$10.1M | 0.42% | 90 |
|
|
2025
Q1 | $8.44M | Sell |
19,410
-9,629
| -33% | -$3.87M | 0.21% | 126 |
|
|
2024
Q4 | $10.7M | Sell |
29,039
-32,438
| -53% | -$13.6M | 0.26% | 118 |
|
|
2024
Q3 | $32M | Sell |
61,477
-11,423
| -16% | -$6.1M | 0.73% | 32 |
|
|
2024
Q2 | $39.5M | Sell |
72,900
-5,785
| -7% | -$3.06M | 0.85% | 20 |
|
|
2024
Q1 | $40.8M | Sell |
78,685
-3,965
| -5% | -$1.97M | 0.81% | 26 |
|
|
2023
Q4 | $39M | Sell |
82,650
-1,327
| -2% | -$614K | 0.8% | 26 |
|
|
2023
Q3 | $36.6M | Sell |
83,977
-1,159
| -1% | -$526K | 0.77% | 32 |
|
|
2023
Q2 | $37.8M | Sell |
85,136
-3,053
| -3% | -$1.41M | 0.74% | 34 |
|
|
2023
Q1 | $40.6M | Buy |
88,189
+4,438
| +5% | +$2.11M | 0.78% | 29 |
|
|
2022
Q4 | $43M | Sell |
83,751
-3,793
| -4% | -$1.93M | 0.84% | 21 |
|
|
2022
Q3 | $39.8M | Buy |
87,544
+9,644
| +12% | +$4.61M | 0.79% | 29 |
|
|
2022
Q2 | $37.6M | Buy |
77,900
+9,011
| +13% | +$4.46M | 0.68% | 43 |
|
|
2022
Q1 | $33.8M | Buy |
68,889
+52,675
| +325% | +$24.1M | 0.51% | 78 |
|
|
2021
Q4 | $7.52M | Sell |
16,214
-1,648
| -9% | -$693K | 0.1% | 170 |
|
|
2021
Q3 | $6.66M | Buy |
17,862
+5,227
| +41% | +$1.99M | 0.09% | 168 |
|
|
2021
Q2 | $4.83M | Buy |
12,635
+8,557
| +210% | +$3.27M | 0.06% | 188 |
|
|
2021
Q1 | $1.46M | Buy |
4,078
+2,543
| +166% | +$818K | 0.02% | 333 |
|
|
2020
Q4 | $493K | Sell |
1,535
-39,744
| -96% | -$12.2M | 0.01% | 614 |
|
|
2020
Q3 | $11.1M | Sell |
41,279
-8,814
| -18% | -$2.37M | 0.13% | 160 |
|
|
2020
Q2 | $13.2M | Buy |
50,093
+5,999
| +14% | +$1.6M | 0.16% | 158 |
|
|
2020
Q1 | $10M | Sell |
44,094
-4,338
| -9% | -$1.18M | 0.13% | 177 |
|
|
2019
Q4 | $14.6M | Sell |
48,432
-9,802
| -17% | -$2.7M | 0.15% | 175 |
|
|
2019
Q3 | $14M | Buy |
58,234
+25,199
| +76% | +$6.9M | 0.14% | 171 |
|
|
2019
Q2 | $9.32M | Sell |
33,035
-138,180
| -81% | -$37.7M | 0.1% | 230 |
|
|
2019
Q1 | $49.1M | Buy |
171,215
+11,977
| +8% | +$3.46M | 0.53% | 40 |
|
|
2018
Q4 | $41.8M | Buy |
159,238
+6,159
| +4% | +$1.69M | 0.55% | 40 |
|
|
2018
Q3 | $42M | Buy |
153,079
+900
| +0.6% | +$234K | 0.49% | 61 |
|
|
2018
Q2 | $36.2M | Buy |
152,179
+1,851
| +1% | +$429K | 0.45% | 70 |
|
|
2018
Q1 | $33M | Sell |
150,328
-1,243
| -0.8% | -$292K | 0.42% | 79 |
|
|
2017
Q4 | $34.1M | Sell |
151,571
-18,043
| -11% | -$3.84M | 0.45% | 72 |
|
|
2017
Q3 | $32.2M | Buy |
+169,614
| New | +$32.3M | 0.43% | 73 |
|
|
2016
Q3 | – | Sell |
-50,741
| Closed | -$6.67M | – | 959 |
|
|
2016
Q2 | $6.67M | Hold |
50,741
| – | – | 0.11% | 221 |
|
|
2016
Q1 | $7.05M | Hold |
50,741
| – | – | 0.14% | 207 |
|
|
2015
Q4 | $7.08M | Sell |
50,741
-18,109
| -26% | -$2.49M | 0.16% | 191 |
|
|
2015
Q3 | $9.64M | Sell |
68,850
-5,502
| -7% | -$827K | 0.24% | 143 |
|
|
2015
Q2 | $12.2M | Buy |
74,352
+16,448
| +28% | +$2.63M | 0.29% | 114 |
|
|
2015
Q1 | $8.94M | Buy |
57,904
+2,318
| +4% | +$330K | 0.21% | 154 |
|
|
2014
Q4 | $6.99M | Buy |
55,586
+17,475
| +46% | +$2.16M | 0.19% | 162 |
|
|
2014
Q3 | $4.56M | Buy |
38,111
+17,619
| +86% | +$2.02M | 0.14% | 202 |
|
|
2014
Q2 | $2.21M | Sell |
20,492
-7,420
| -27% | -$765K | 0.07% | 296 |
|
|
2014
Q1 | $2.78M | Buy |
27,912
+17,603
| +171% | +$1.59M | 0.09% | 243 |
|
|
2013
Q4 | $953K | Buy |
+10,309
| New | +$916K | 0.03% | 562 |
|
Other funds holding ELV
Martingale Asset Management's ELV Position: Q3 2025 in Review
Martingale Asset Management sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 44,400 shares — an estimated $17.3M sold.
Martingale Asset Management first reported a position in ELV in Q4 2013 and held it in 43 quarters. The position peaked at $49.1M in Q1 2019. 1,511 funds tracked by Wall St. Rank hold ELV as of Q3 2025.
- Martingale Asset Management reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
- Martingale Asset Management sold 44,400 Elevance Health shares in Q3 2025, an estimated $17.3M.
- Martingale Asset Management first reported a position in Elevance Health in Q4 2013 and held it in 43 quarters.
- Martingale Asset Management's Elevance Health position peaked at $49.1M in Q1 2019.
- 1,511 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.
Based on Martingale Asset Management's 13F filing for Q3 2025, filed 13 Nov 2025.